- Home
- ANIX vs XBIT Comparison
ANIX vs XBIT Comparison
Compare ANIX & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- XBIT
- Stock Information
- Founded
- ANIX 1982
- XBIT 2005
- Country
- ANIX United States
- XBIT United States
- Employees
- ANIX N/A
- XBIT N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- XBIT Pharmaceuticals and Biotechnology
- Sector
- ANIX Health Care
- XBIT Health Care
- Exchange
- ANIX Nasdaq
- XBIT Nasdaq
- Market Cap
- ANIX 88.9M
- XBIT 89.6M
- IPO Year
- ANIX 1987
- XBIT 2015
- Fundamental
- Price
- ANIX $3.38
- XBIT $2.50
- Analyst Decision
- ANIX Strong Buy
- XBIT
- Analyst Count
- ANIX 3
- XBIT 0
- Target Price
- ANIX $9.00
- XBIT N/A
- AVG Volume (30 Days)
- ANIX 236.6K
- XBIT 52.8K
- Earning Date
- ANIX 05-28-2025
- XBIT 08-11-2025
- Dividend Yield
- ANIX N/A
- XBIT N/A
- EPS Growth
- ANIX N/A
- XBIT N/A
- EPS
- ANIX N/A
- XBIT N/A
- Revenue
- ANIX N/A
- XBIT N/A
- Revenue This Year
- ANIX N/A
- XBIT N/A
- Revenue Next Year
- ANIX N/A
- XBIT N/A
- P/E Ratio
- ANIX N/A
- XBIT N/A
- Revenue Growth
- ANIX N/A
- XBIT N/A
- 52 Week Low
- ANIX $2.07
- XBIT $2.50
- 52 Week High
- ANIX $4.20
- XBIT $8.32
- Technical
- Relative Strength Index (RSI)
- ANIX 57.87
- XBIT 33.01
- Support Level
- ANIX $3.30
- XBIT $2.57
- Resistance Level
- ANIX $3.80
- XBIT $2.78
- Average True Range (ATR)
- ANIX 0.25
- XBIT 0.14
- MACD
- ANIX 0.05
- XBIT -0.03
- Stochastic Oscillator
- ANIX 61.47
- XBIT 0.00
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc a cancer-focused biotechnology company, develops vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.